BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 204171)

  • 1. The treatment of lung cancer.
    Zubrod CG; Selawry O
    Adv Intern Med; 1978; 23():451-67. PubMed ID: 204171
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy with adriamycin and cyclophosphamide (with or without radiation therapy) for carcinoma of the lung.
    Herman TS; Jones SE; McMahon LJ; Lloyd RE; Heusinkveld RS; Miller RC; Salmon SE
    Cancer Treat Rep; 1977 Aug; 61(5):875-9. PubMed ID: 196753
    [No Abstract]   [Full Text] [Related]  

  • 4. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
    Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
    Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical research on the treatment of locally advanced lung cancer: final report of VALG Protocol 13 Limited.
    Petrovich Z; Ohanian M; Cox J
    Cancer; 1978 Sep; 42(3):1129-34. PubMed ID: 212170
    [No Abstract]   [Full Text] [Related]  

  • 6. [Multiple primary cancer of the lung and larynx].
    Trakhtenberg AKh; Ol'shanskiĭ VO; Frank GA; Kim IK; Anikin VA
    Vopr Onkol; 1986; 32(2):28-33. PubMed ID: 3008434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
    Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
    Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of immunotherapy in the combined treatment of lung cancer].
    Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
    Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
    [No Abstract]   [Full Text] [Related]  

  • 9. Lung cancer patients with chronic obstructive pulmonary disease.
    Kurishima K; Satoh H; Ishikawa H; Yamashita YT; Homma T; Ohtsuka M; Sekizawa K
    Oncol Rep; 2001; 8(1):63-5. PubMed ID: 11115570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lung.
    Young JA; Dillman RO; Seagren SL; Taetle R; Rentschler RE; Lea JW; Lehar TJ; Green MR; Stanton W; Mendelsohn J; Royston I
    Cancer Treat Rep; 1982 Jun; 66(6):1399-401. PubMed ID: 6282459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What is safe in the treatment of small-cell bronchial carcinoma?].
    Gropp C; Havemann K
    Internist (Berl); 1980 Dec; 21(12):705-10. PubMed ID: 6162816
    [No Abstract]   [Full Text] [Related]  

  • 12. [A randomized comparison of radiotherapy with CAP and CVP in non-small cell lung cancer].
    Yoneda S; Homma T; Yoshida S; Noguchi Y; Fukuda Y; Nakata M; Sakura M
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2870-1. PubMed ID: 3019254
    [No Abstract]   [Full Text] [Related]  

  • 13. The current management of malignancy. IV.-Cancer of the lung.
    Panettiere FJ
    Alaska Med; 1975 May; 17(3):35-41. PubMed ID: 237422
    [No Abstract]   [Full Text] [Related]  

  • 14. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.
    Takita H; Marabella PC; Edgerton F; Rizzo D
    Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692
    [No Abstract]   [Full Text] [Related]  

  • 15. [An analysis of the therapeutic effects of 120 cases of lung cancer in the elderly].
    Xu YN
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Dec; 8(6):321-4, 372. PubMed ID: 3015519
    [No Abstract]   [Full Text] [Related]  

  • 16. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
    Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
    Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative treatment of patients with small-cell lung cancer.
    Kas'yanenko IV
    Cancer Treat Rep; 1976 Oct; 60(10):1483-5. PubMed ID: 191188
    [No Abstract]   [Full Text] [Related]  

  • 18. [Small cell lung carcinoma in a 20-year-old patient].
    Gómez-Mendieta MA; Alvarez-Sala R; Prado C; Felíu J
    An Med Interna; 1999 Oct; 16(10):541. PubMed ID: 10603675
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of monitoring serum carcinoembryonic antigen (CEA) levels for prognosis of patients with lung cancer treated by non-surgical methods].
    Ochnio J; Rogińska E; Kwiek S; Rowińska-Zakrzewska E
    Pneumonol Pol; 1984 Jul; 52(7):321-9. PubMed ID: 6093066
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Prolonged survival of patients with extensive oat cell carcinoma treated with radiotherapy and cyclophosphamide (NSC-26271), vincristine (NSC-67574), and methotrexate (NSC-7040).
    Bitran J; Golomb HM; Desser RK; Colman M
    Cancer Treat Rep; 1976 Mar; 60(3):221-3. PubMed ID: 177208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.